Comparison
Why is Acurx Pharmaceuticals, Inc. ?
Unrated Stock - No Analysis Available
Quality key factors
Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
0.00%
EBIT to Interest (avg)
-4.48
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-2.01
Sales to Capital Employed (avg)
0
Tax Ratio
4.10%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
22.15%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.53
EV to EBIT
-0.25
EV to EBITDA
-0.25
EV to Capital Employed
-1.50
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-1708.19%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bearish
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
No Trend
Technical Movement
9What is working for the Company
NET PROFIT(HY)
Higher at USD -4.4 MM
RAW MATERIAL COST(Y)
Fallen by 0% (YoY
EPS(Q)
Highest at USD -1.89
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Acurx Pharmaceuticals, Inc.
Net Profit
Higher at USD -4.4 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Net Profit
At USD -4.4 MM has Grown at 48.29%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD -1.89
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales






